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ABSTRACT
Migraine is a neurological entity and a well-known independent risk factor for cerebral infarction, which mostly afflicts 
the young female population. Researching focal neurological signs in this subset of the population with the diagnosis of 
a neurological ischemic event should always take into account the migraine as the etiology or as an associated factor. 
The etiology of central nervous system (CNS) ischemia is considerable. Migraine, although rare, also may be included 
in this vast etiological range, which is called migrainous infarction. In this setting, the diagnostic criteria required for 
this diagnosis is extensive. Herein, we present the case of a female adolescent who submitted to the emergency facility 
complaining of diplopia, dysarthria, and imbalance, which started concomitantly with a migrainous crisis with aura—a 
challenging clinical case that required extensive research to address all possible differential diagnoses. 
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CASE REPORT
A 16-year-old female patient was admitted to 
the emergency unit complaining of a pulsatile, frontal 
headache over the last 12 hours accompanied by nausea 
with photo- and phonophobia. The symptoms evolved 
with diplopia, difficulty in performing adduction of the 
right eye, and dysarthria; imbalance started subtly about 
1 hour after the onset of pain. The patient reported 
that at the beginning of the symptoms she presented 
partial loss of vision on the lateral field of the right 
eye, scotomas, and blurry vision, which lasted about 
30 minutes, with spontaneous resolution. She denied 
fever or any other neurological complaint, or the use 
of oral contraceptives. She took dipyrone before going 
to the emergency department. Her medical history 
included the diagnosis of migraine that started with 
the menarche at the age of 10 years, when she began 
presenting premenstrual migraine of variable intensity 
with visual aura, with predominant laterality also 
variable. The previous aura was characterized from 
scotomas, blurred vision, tunnel vision, and partial loss 
of vision, which was always reversible, with a maximum 
duration of 60 minutes. The patient did not remember 
having presented symptoms like diplopia or ataxia 
during previous events.
The physical examination revealed tachycardia, 
blood pressure of 150/80 mmHg, and a normal 
temperature. The neurologic examination revealed a 
wakeful, vigilant, and cooperative patient. Visual acuity 
was normal and without alterations on the field of 
vision; her pupils were isochoric and the direct response, 
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the consensual response, and the accommodation of 
the pupils were normal. Paresis of the right eye when 
looking to the left was present (Figure 1), as well as 
diplopia, and a slow saccadic movement of the left 
eye in abduction, with horizontal nystagmus with 
the preservation of ocular convergence. Other cranial 
nerves presented normal function. Strength, sensitivity, 
and deep reflexes were preserved and symmetric. 
At the examination of station when the patient’s feet 
were close together, she swayed backward, which was 
slightly worsened when she closed her eyes. Her gait 
was ataxic and she had a fall tendency to the left. 
Diadochokinesis, appendicular movement speed, and 
the finger-to-nose test were normal, but the heel-shin 
test was dysmetric at the left side. Other systems 
showed no abnormalities.
No improvement in the neurologic examination 
was noted after the patient was medicated with 
metoclopramide, ketoprofen, and dexamethasone; 
however, the pain and nausea did cease. The patient 
was hospitalized and submitted to a thorough 
etiological investigation.
The cerebral computed tomography (CT) and 
the angiotomography were normal. On the second 
day of hospitalization, a partial improvement of the 
symptoms was noted, but the diplopia remained 
steady. The cerebral magnetic resonance imaging 
(MRI) showed a focus of diffusional restriction in the 
paramedian right dorsal portion of the midbrain, 
which was consistent with the topography of the 
ipsilateral medial longitudinal fasciculus, without 
significant expansive effect, exhibiting hyperintense 
focus in T2 and fluid-attenuated inversion recovery 
(FLAIR), which did not show impregnation by the 
contrast medium (Figure 2). The cerebral (Figure 3) 
and cervical MRI angiography and the cerebrospinal 
fluid analysis with protein electrophoresis were normal. 
The electrocardiogram (ECG), echocardiogram, and 
Holter ECG were normal. Biochemical analysis and 
thyroid function tests were normal. Antinuclear 
antibodies (ANA) was positive 1/640 exhibiting 
a fine nuclear dot pattern. However, antibodies 
anti-SS-B/LA, anti-SS-A/Ro, anti-SM, anti-double 
strain DNA, anti-neutrophil cytoplasmic antibody, and 
lupus anticoagulant tests were negative. Complement 
fractions C3 and C4 were normal. Anti-HIV, HBsAg, 
and anti-hepatitis C virus were negative. Acute phase 
proteins, serum lactate, and muscle enzymes were 
normal. The serum dosage of protein C, homocysteine, 
and antithrombin III tests were normal. The search for 
factor V Leiden was negative.
Thus,  the c l in ica l  features ,  the imaging 
examinations, and the thorough investigation were 
consistent with the diagnosis of cerebral infarction 
without any risk factor other than migraine. The patient 
was prescribed salicylates and propranolol with gradual 
improvement. She was referred to an outpatient clinic 
for follow-up.
DISCUSSION
The interpretation of the physical examination, 
the laboratory testing, and the imaging, renders the 
conclusion of an internuclear ophthalmoparesis (INO) 
of ischemic origin.
INO is a syndrome derived from the medial 
longitudinal fasciculus (MLF) injury. The MLF is a set 
of myelinated fibers that extends along the entire 
brainstem and the spinal cord.1,2 These fibers present 
a varied origin and destiny in their paths and stand as 
Figure 1. Paresis of the right eye when looking to the left.
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an integration tool. In the pons and the midbrain, the 
MLF stays close to the midline, ventrally to the fourth 
ventricle and the cerebral aqueduct. The center of the 
conjugate gaze lies between the dorsal pons and the 
mesencephalic tegmentum where the MLF harbors 
the internuclear fibers of the sixth and third cranial 
nerves.3 Diplopia is an important symptom of INO, but 
in mild lesions it may present as a visual blur, which 
is unleashed when the conjugate gaze is directed 
towards the opposite side of the injured eye, or during 
the adduction of the affected eye.3
The most frequent causes of INO are cerebrovascular 
diseases in elderly patients, and demyelinating diseases, 
which mostly afflict the younger female patients.3-5
The other clinical features of our patient, which are 
consistent with INO and lead to anatomic localization 
are: (i) normal eye convergence (since the fibers 
responsible for the convergence are cranially located 
in the midbrain); (ii) nystagmus in adduction of the 
non-paretic eye;6 and (iii) sensitive and/or motor 
dysmetria on the left inferior limb.3
As shown in the MRI (Figure 2), the ischemia is 
located in the highly concentrated area of motor-related 
Figure 2. Brain MRI – Axial T2-weighted (A) and FLAIR (B) showing hyperintensity focus in the right periaqueductal 
region of the midbrain (black arrow). Axial ADC map (C) and DWI (D) show ischemic insult characterized by the 
restriction of free water molecules in the same region of the midbrain (black arrow). ADC = apparent diffusion 
coefficient; DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery sequence; MRI = magnetic 
resonance imaging.
Figure 3. Cerebral magnetic resonance angiography (3D reconstructions). Oblique axial (A) and oblique coronal 
(B) images show normal intracranial arteries. 
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pathways, such as the rubrospinal tract, the medial 
lemniscus, and the pontocerebellar and tectospinal 
fibers of head adjustment to cocleo-vestibular stimuli. 
Therefore, motor and sensitive ataxia may be present 
if the area of ischemia is large enough.1
The cause of cerebral ischemia in children and 
young adults substantially differs from that of the 
adult/elderly population.7 Acute ischemic stroke 
accounts for approximately 50% of all strokes in 
children.8 The incidence among children is low and 
varies according to race (2.6/100,000 white children 
and 3.1/100,000 black children).9
There are many differential diagnoses that can 
cause focal neurologic symptoms in children and young 
adults, as shown in Table 1.
The etiology also varies according to gender, 
age, and geographic localization.9 The main causes 
of ischemic stroke in this subset of the population are 
represented by congenital cardiac diseases and sickle 
cell anemia.17 However, up to 50% of pediatric patients 
do not present any etiological evidence.18 The main 
risk factors found in patients with stroke in the child 
population are presented in Table 2. The prevalence 
of risk factors differ in the literature.7,10
The management of stroke in children and young 
adults can be divided into initial and general supportive 
measures, diagnostic modalities, and appropriate 
treatment to the type of stroke identified, if possible.10
General supportive measures include maintaining 
normal oxygenation, treating dehydration, correcting 
anemia, controlling systemic hypertension with mild 
permissive high levels, normalizing serum glucose, and 
controlling fever.10
An imaging test must be done to exclude a 
hemorrhagic cause of stroke after the initial supportive 
measures. The non-contrast CT has great sensitivity to 
exclude any acute bleeding, and MRI can be useful for 
the early detection of an infarction. MR arteriography, 
CT angiography, or catheter angiography are used 
to study the vascular anatomy and to confirm vessel 
patency.10 Other investigations that may be useful 
are an ECG, a chest radiograph, and transthoracic or 
transesophageal echocardiography.10
There are no guidelines that establish the 
laboratory tests that should be assessed in the children 
and young adult population,10 but it makes sense for 
the tests to include those that can help the differential 
diagnosis (Table 1) and to find the possible risk factors 
(Table 2).
In our case, a thorough diagnostic work-up focused 
on the risk factors that were potentially associated with 
cerebral ischemic events, and migraine was the unique 
detected risk factor. The presence of the positive 
ANA in the absence of detectable autoantibodies and 
Table 1. Differential diagnosis of arterial ischemic 
stroke in children8,10-16
Venous occlusion of cerebral veins or sinuses
Hemorrhagic stroke
Complicated migraine 
Transient postictal focal neurologic symptoms (Todd’s 
paresis)
Intracranial neoplasm
Intracranial infections (meningitis, brain abscess, herpes 
simplex encephalitis)
Metabolic disorders (hypoglycemia, MELAS)
•	 Hypoglycemia
•	 MELAS
Traumatic hematomas (extradural, subdural)
Demyelinating conditions
MELAS = mitochondrial myopathy, encephalopathy, lactic 
acidosis, and stroke-like symptoms.
Table 2. Risk factors of stroke in childhood7,10,13
Cardiac disorders (congenital heart disease, patent 
foramen ovale, after cardiac surgery [immediate or not] 
and catheterization, acquired heart disease [rheumatic 
heart disease, cardiomyopathies, endocarditis, prosthetic 
valves]) 
Hematologic disorders (sickle cell disease, 
prothrombotic states [acquired thrombophilia, 
genetic thrombophilia], iron deficiency, hematological 
malignancy)
Infection (varicella, HIV, meningitis/encephalitis, 
pharyngitis, otitis media, sinusitis, matoiditis, sepsis)
Vascular disorders (arteriovenous malformations, 
moyamoya, arterial dissection, vasculitis)
Syndromic and metabolic disorders (Marfan 
syndrome, homocysteinuria, nutritional deficiencies [folic 
acid, vitamin B12], Down syndrome)
Connective tissue disease
Extracranial solid tumors
Acidosis, anoxia, dehydration, shock
Trauma
Drugs (oral contraceptive, amphetamines, ecstasy, 
cocaine, phencyclidine, glue sniffing, ergot alkaloids)
Migraine
Ventriculoperitoneal shunt
PHACES syndrome
Risk factors for atherosclerosis in adulthood 
(hypertension, hyperlipidemia, type 1 diabetes mellitus)
PHACES = malformations of the posterior fossa, facial 
hemangioma, arterial cerebrovascular anomalies, cardio-
vascular anomalies, abnormalities of the eye and sternum.
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normal complement was interpreted as with feeble 
correlation with any autoimmunity disorder; therefore 
the positive ANA could be explained by the acute 
event.19
Migraine is a chronic neurovascular entity, which 
is present in 11% of the general population (men 
and women) of all ages. In the female population of 
all ages, migraine is present in 17%; however, this 
increases to 23.5% between the ages of 18 and 44 
years old.20,21
Migraine is an independent risk factor for 
cardiovascular diseases. Patients with the diagnosis of 
migraine have a 1.5 times greater risk of developing 
acute myocardial infarction, angina, and stroke,22 
which increases mortality by cardiovascular diseases 
by 1.37 times.23 The main risk is related to cerebral 
ischemia.24,25
The diagnostic work-up of a focal deficit in a 
young woman should always consider the migraine as 
a potential risk factor or the etiology of the ischemic 
event, since in this subset of the population the 
etiology of stroke is determined in only 40% of cases.26
A stroke in a person with migraine should be 
differentiated into: (i) the cerebral infarction of other 
cause in a person that has migraine (cerebral ischemia 
associated with migraine); (ii) the cerebral infarction 
of other cause presenting with symptoms resembling 
migraine with aura; and (iii) the migrainous infarction. 
They present diverse physiopathological mechanisms, 
and the therapeutic approach should be different.27
Cerebral ischemia associated with migraine 
represents every cerebral ischemic event in patients 
diagnosed with migraine. The patient who has a stroke 
during a migraine crisis with neurological focal signs 
that are different from the previous aura could be 
diagnosed with a cerebral infarction of other cause 
presenting with symptoms resembling migraine with 
aura.27
Migraine is a risk factor associated with cerebral 
ischemia mainly in women under the age of 45 years 
who use an oral contraceptive and smoke tobacco 
(independent risk factors). Migraine with aura presents 
the relative risk of 2.16 (confidence interval 95%, 
1.53-3.03), although there are controversies in the 
literature.24,28,29 The presence of migraine in children 
with ischemic stroke in the study of Mackay et al.9 was 
3%. The frequency of migraine attacks also affects the 
risk of ischemic stroke; that is, the greater the number 
of attacks, the greater the risk.
In addition to being the cause of a stroke, 
migraine enhances the risk of CNS ischemia by 
different mechanisms. There are many hypotheses to 
explain the association of migraine and stroke, which 
include (i) the adverse effect of migraine-specific 
medication;30 (ii) genetic associations that cause a 
predisposition to the hyperactivity of vessels; (iii) 
endothelial dysfunction that causes a predisposition 
to atheromatous plaque formation and its instability 
associated with procoagulant, proliferative, and 
proinflammatory states; and (iv) the prevalence of some 
conditions, such as arterial dissection; the presence of 
a patent foramen ovale; and clotting disorders, such 
as thrombophilia.31 Migraine also increases the risk of 
hemorrhagic stroke by still unknown causes.32
According to the third edition (2013) of the 
International Classification of Headache Disorders,27 
migrainous infarction is defined as: “One or more 
migraine aura symptoms associated with an ischaemic 
brain lesion in the appropriate territory demonstrated 
by neuroimaging” (p. 651). Also, as diagnostic criteria, 
the aura must be typical of previous attacks, the focal 
deficit must remain longer than 60 minutes and it 
must be associated with the pain crisis, which fulfils 
the criteria of a migraine attack not explained by any 
other cause. The incidence of migrainous infarction is 
low, accounting for 0.2-0.5% of all cerebral ischemic 
causes.33,34 The physiopathology is still uncertain; 
however, the main hypothesis relates to an imbalance 
in the vessels’ control with severe vasoconstriction 
followed by downstream ischemia.30 The territory of 
the posterior circulation is mostly involved (70-82%). 
Young women are more affected, probably with a 
bias of selection, since the migraine with aura by itself 
is more frequent in this population.31 The imaging 
examinations more often reveal single or multiple 
small lesions limited to an unique vascular territory.35 
The prognosis is generally favorable with complete 
recovery of the neurological deficits.36 Our patient 
could not meet the criteria for migrainous infarction, 
because the presented symptoms were not part of the 
crises previously presented.
The management of migraine in patients with 
ischemic stroke involves the avoidance of some drugs 
that can induce migraine in those patients, such as 
cilostazol37 and dipyridamole,38 and prescribing a 
treatment for preventing migraine.30 A beta-adrenergic 
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blocker and a calcium channel blocker are well 
established for this propose.39,40 Statins, angiotensin 
receptor blockers, and angiotensin-converting-enzyme 
inhibitors have been reported as effective for migraine 
prophylaxis.41-43
The pharmacological prevention of stroke in 
migraineurs is not well established.30 It is important to 
eliminate modifiable risk factors, such as smoking and 
the use of oral contraceptives. Antihypertensives and 
statins must be used according to the indications. There 
are no recommendations for the use of antithrombotics 
to reduce the risk of stroke in this population.30
By definition and by exclusion, after extensive 
diagnostic investigation, we arrived at the diagnosis 
of cerebral infarction of other cause presenting with 
symptoms resembling migraine with aura, since the 
patient presented a typical episode of migraine with 
visual aura, and developed focal neurological signs 
that were different from those presented in previous 
auras, which made it impossible to fulfill all the criteria 
for migrainous infarction, excluding the main causes 
investigated for a cerebral infarction.
CONCLUSION
The case presented herein illustrates the case of 
a midbrain ischemic stroke in a young female, which 
was confirmed by the medical history, the neurological 
examination, the imaging examinations, and the 
extensive work-up, which ruled out a wide range 
of other possible etiologies. Although migrainous 
infarction is not common in medical practice, it is 
important to be reminded of its etiological role in 
young patients with headache and a lasting focal 
deficit.
Patients with migraine should be advised to 
prevent the modifiable risks factors, such as tobacco 
smoking, oral contraceptive use, obesity, a sedentary 
lifestyle, and treat—when indicated—the chronic 
migraine and other comorbidities, such as diabetes, 
hypertension, and dyslipidemia, to decrease the 
likelihood of ischemic episodes.
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